Shares of Babcock & Wilcox slid 10.2% to $16.73 on June 5 as investors rushed to lock in profits from a rally that has transformed a former penny stock into a mid-cap darling. Over the past 52 weeks, BW has ranged from a low of $0.76 to a high of $22.03 — a breathtaking swing that underscores just how much is riding on a single strategic pivot. The broader market's risk-off mood on rate and macro worries gave sellers an excuse to hit the exits.
A $2.4 Billion Contract Rewrote the Entire Company
Shares first surged 33% after B&W announced it received a notice to proceed on a $2.4 billion power generation project for Applied Digital-backed Base Electron.
That multi-year agreement for four natural gas-fired power plants serves as the foundation for a total backlog of $2.7 billion. For a company with a $2.6 billion market cap, concentration in one mega-contract means enormous upside and enormous execution risk — any delay or cost overrun could be devastating.
Q1 Numbers Beat Every Expectation
Adjusted EBITDA hit $16.1 million, a 296% increase year over year, while revenue came in at $214 million, up 44%.
On a GAAP basis, B&W posted a $79.6 million net loss due to a non-cash warrant charge, though adjusted net income reached $2.2 million. The gap between those headline numbers shows a balance sheet still carrying complicated financial instruments that can obscure the real operating picture.
Fresh Shares and Lawsuits Add Pressure
B&W closed a $200 million stock sale at $18.50 per share, adding 10.8 million new shares. That dilution gives the company cash for debt paydown and project ramp, but it also adds supply to a thinly traded stock. Meanwhile, multiple securities class-action lawsuits allege the company misled institutional shareholders , with a June 15 lead-plaintiff deadline looming.
Valuation Models Are All Over the Map
One model pegs fair value at just $2.13, implying the stock is overvalued by 775%.
A discounted-cash-flow model estimates intrinsic value at $21.11, suggesting BW is roughly 14.5% undervalued.
Analysts' consensus price target sits at just $8. That extreme divergence tells shareholders one thing: the market is pricing a future that has yet to be built. Today's pullback may be healthy profit-taking, but the real test comes when B&W has to actually deliver on those power plants.